Nov 20, 2025 • Zacks Commentary
BULLISH
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 19, 2025 • Zacks Commentary
BULLISH
Theravance Biopharma ( TBPH ) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 13, 2025 • Benzinga
SOMEWHAT-BULLISH
Beacon Biosignals Raises $86M to Accelerate AI-Driven Insights into Brain Health
BOSTON, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- Beacon Biosignals, a leading neurotechnology company powering AI-driven diagnostics and precision medicines for the brain, today announced an oversubscribed $86 million Series B to build the world's largest neurodiagnostic dataset and advance the ...
Nov 05, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Innoviva ( INVA ) Q3 Earnings and Revenues Beat Estimates
Innoviva (INVA) delivered earnings and revenue surprises of +134.78% and +14.78%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 04, 2025 • Zacks Commentary
NEUTRAL
Pfizer ( PFE ) Surpasses Q3 Earnings and Revenue Estimates
Pfizer (PFE) delivered earnings and revenue surprises of +31.82% and +0.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 31, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
AbbVie ( ABBV ) Q3 Earnings and Revenues Surpass Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of +5.08% and +1.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?